Celestica price target raised to $115 from $75 at RBC Capital

RBC Capital raised the firm’s price target on Celestica (CLS) to $115 from $75 and keeps an Outperform rating on the shares. Celestica’s shares are poised for another strong year in 2025 given the firm’s view that the company is likely to see upside to consensus estimates and the upwards valuation re-rating in the shares is likely to continue, the analyst tells investors in a research note. RBC is also raising its FY25 EPS view by 13c to $4.55 and its FY26 view by 33c to $5.43.